Exact Sciences Corp reports results for the quarter ended December 31 - Earnings Summary

• Exact Sciences Corp EXAS.OQ reported a quarterly adjusted loss of $4.67​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -27 cents. The mean expectation of twenty four analysts for the quarter was for a loss of 31 cents per share. Wall Street expected results to range from -44 cents to -21 cents per share.

• Revenue rose 10.3% to $713.42 million from a year ago; analysts expected $701.30 million.

• Exact Sciences Corp's reported EPS for the quarter was a loss of $4.67​.

• The company reported a quarterly loss of $864.59 million.

• Exact Sciences Corp shares had fallen by 11.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 4.2% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 23 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Exact Sciences Corp is $70.00

This summary was machine generated from LSEG data February 19 at 10:57 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)